全心脏高分辨率联合T1和T1ρ定量磁共振成像技术研究及其在心肌梗死诊断中的应用
批准号:
82102027
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
齐海坤
依托单位:
学科分类:
磁共振成像
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
齐海坤
中文摘要
延迟强化心脏磁共振成像是目前对心肌梗死最具特异性和敏感性的诊断方法。然而延迟强化成像需要注射钆造影剂,不适用于肾功能障碍病人。非强化心肌参数T1和T1ρ均展示了区分梗死和健康心肌的潜力,但是目前仍缺乏研究比较二者诊断心肌梗死的能力。心肌参数测量通常需要在病人的一次屏气中采集多个对比度图像,有限的屏气时间限制了成像范围和空间分辨率,影响诊断。并且现有技术无法在一次扫描中同时测量T1和T1ρ,如果分别测量,两者之间的配准误差会影响比较结果。本项目将开发自由呼吸的全心脏高分辨率T1和T1ρ同时测量技术,利用图像导航矫正呼吸运动实现高采集效率,结合4-5倍稀疏采样,将扫描时间降低到临床可接受的5分钟内。基于开发出的新技术,本项目将开展临床研究,系统比较T1、T1ρ以及联合T1和T1ρ这三种参数图对心肌梗死病人的诊断效果,探究内源性对比的心肌T1/T1ρ参数图取代外源性对比的延迟强化成像的可行性。
英文摘要
Late gadolinium enhanced cardiac magnetic resonance imaging (LGE CMR) has been widely used in clinical practice for diagnosis of myocardial infarction (MI) due to its superior specificity and sensitivity. However, LGE CMR requires injection of gadolinium-based contrast agents, which is contradictive to patients with kidney dysfunction. Native myocardial T1 and T1ρ mapping by CMR has respectively shown the potential for differentiating infarcted and heathy myocardium. However, studies comparing the performance of the two parameters in diagnosing MI are still lacking. In addition, current myocardial mapping techniques commonly acquire a series of different contrast-weighted images under a single breath-hold, which limits the achievable imaging coverage and spatial resolution, affecting the clinical diagnosis. Furthermore, there is currently no available technique for simultaneous T1 and T1ρ quantification in a single scan. If measured separately, the possible mis-registration between T1 and T1ρ maps will influence their comparison..In this project, we will develop a free-breathing whole-heart high-resolution joint T1 and T1ρ mapping technique, where an image navigator (iNAV) will be used to measure and correct respiratory motion to achieve high respiratory acquisition efficiency. With 4x-5x undersampling for further acceleration, the scan time of the proposed CMR sequence will be reduced to a clinically acceptable 5 minutes. The developed technique will be used to image MI patients in a clinical study to systematically compare the diagnostic performance of the three sets of parametric maps: T1; T1ρ; joint T1 and T1ρ, as well as to investigate the feasibility of replacing exogenous contrast LGE CMR with endogenous contrast T1/T1ρ mapping.
本项目聚焦于开发全心脏高分辨率联合T1和T1ρ定量磁共振成像技术,基于此技术探究非造影剂强化的T1和T1ρ参数在心肌梗死诊断中的应用价值。本项目研究按照任务计划书实施,提出了适用于3.0T高场磁共振的T1ρ准备脉冲,首次实现了高场磁共振下的三维全心脏T1ρ参数定量;基于优化的T1ρ准备脉冲,开发了自由呼吸二维心脏多参数同时定量磁共振成像和非刚性运动矫正的三维全心脏T1和T1ρ同时测量磁共振成像技术,完成了项目中的关键技术研发。基于开发的心脏多参数同时定量技术,项目探究了非造影剂参数诊断心肌纤维化的准确性,结果表明平扫心肌参数诊断心肌纤维化具有一定的可行性,且基于T2和T1ρ参数计算出的心肌纤维化指数的诊断准确性优于T1。最后,项目探究了基于平扫心脏磁共振生成虚拟延迟增强图像的可行性,为非造影剂增强心肌梗死诊断指明了后续研究方向。本项目为进一步发展无对比心脏MR技术提供了重要的技术参考。. 本项目发表SCI论文9篇,申请国家发明专利2项。本项目提出的自由呼吸多参数同时定量技术可以极大简化心脏参数定量采集过程,已在多家医院安装使用,有望实现临床转化。本项目培养了2名博士生,3名硕士生。项目组研究生多次被评为校优秀学生和三好学生,博士生吕振峰获得了磁共振成像领域权威会议ISMRM的教育助学金,并获得了2024年研究生国家奖学金。本项目较好完成了任务计划书中的科学研究目标和人才培养目标。
国内基金
海外基金